Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder
- 188 Downloads
A strong link exists between gastroesophageal reflux disease (GERD) and airway diseases. Surgical therapy has been recommended as it is more effective than medical therapy in the short term, but there is little data on the effectiveness of surgery long-term. We analyzed the long-term response of GERD-related airway disease after laparoscopic anti-reflux surgery (LARS).
In 2004, we contacted 128 patients with airway symptoms and GERD who underwent laparoscopic antireflux surgery (LARS) between 12/1993 and 12/2002. At median follow-up of 53 months (19–110 mo) we studied the effects on symptoms, esophageal acid exposure, and medication use and we analyzed the data to determine predictors of successful resolution of airway symptoms.
Cough, hoarseness, wheezing, sore throat, and dyspnea improved in 65-75% of patients. Heartburn improved in 91 % (105/116) of patients and regurgitation in 92% (90/98). The response rate for airway symptoms was the same in patients with and without heartburn. Almost every patient took proton pump inhibitors (PPIs) preoperatively (99%, 127/128) and 61% (n = 78) were taking double or triple dose. Postoperatively, 33% (n = 45) of patients were using daily anti-acid therapy but no one was on double dose. The only factor that predicted a successful surgical outcome was the presence of abnormal reflux in the pharynx as determined by 24-hour pharyngeal pH monitoring. One hundred eleven (87%) patients rated their results as excellent (n = 78, 57%) or good (n = 33, 24%).
LARS provides an effective and durable barrier to reflux, and in so doing improves GERD-related airway symptoms in ∼70% of patients and improves typical GERD symptoms in ∼90% of patients. Pharyngeal pH monitoring identifies those patients more likely to benefit from LARS, but better diagnostic tools are needed to improve the response of airway symptoms to that of typical esophageal symptoms.
KeywordsOesophageal Clinical papers Trials Research Digestive GORD GERD (Gastro-oesophageal reflux disease) General Oesophageal
This research was supported by the Dennis and Mary Wise Fund for esophageal research.
- 4.Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Linder D, Stolte M, Malfertheiner P (2003) Prevalence of extra esophageal manifestations in gastroesophageal reflux disease: an analysis based on the ProGERD study. Aliment Pharmacol Ther 17: 1515–1520PubMedCrossRefGoogle Scholar
- 5.Koufman JA (1991) The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(4 Pt 2 Suppl 53): 1–78PubMedGoogle Scholar
- 23.Sullivan SD (2003) Asthma in the United States: recent trends and current status. J Manage Care Pharm 9(5 Suppl): 3–7Google Scholar
- 28.Wetscher GJ, Glaser K, Hinder RA, Perdikis G, Klingler P, Bammer T, Wieschemeyer T, Schwab G, Klinger A, Pointner R (1997) Respiratory symptoms in patients with gastroesophageal reflux disease following medical therapy and following antireflux surgery. Am J Surg 174: 639–642, discussion 42–43PubMedCrossRefGoogle Scholar
- 29.Sontag SJ, O’Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A (2003) Asthmatics with gastroesophageal reflux: long-term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 98: 987–999PubMedGoogle Scholar